Bayforest Capital Ltd Cuts Stock Holdings in Bath & Body Works, Inc. $BBWI

Bayforest Capital Ltd trimmed its position in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 25.7% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 10,510 shares of the company’s stock after selling 3,630 shares during the quarter. Bayforest Capital Ltd’s holdings in Bath & Body Works were worth $315,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently bought and sold shares of the company. Stonehage Fleming Financial Services Holdings Ltd purchased a new position in Bath & Body Works during the 2nd quarter worth $33,000. SVB Wealth LLC purchased a new position in Bath & Body Works during the 1st quarter worth $35,000. Geneos Wealth Management Inc. boosted its holdings in Bath & Body Works by 217.7% during the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock worth $35,000 after acquiring an additional 801 shares during the last quarter. Parallel Advisors LLC boosted its holdings in Bath & Body Works by 63.3% during the 2nd quarter. Parallel Advisors LLC now owns 1,241 shares of the company’s stock worth $37,000 after acquiring an additional 481 shares during the last quarter. Finally, Golden State Wealth Management LLC boosted its holdings in Bath & Body Works by 94.7% during the 1st quarter. Golden State Wealth Management LLC now owns 1,320 shares of the company’s stock worth $40,000 after acquiring an additional 642 shares during the last quarter. 95.14% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on BBWI shares. Morgan Stanley lowered their target price on Bath & Body Works from $19.00 to $18.00 and set an “overweight” rating on the stock in a research note on Friday, September 12th. Barclays lifted their target price on Bath & Body Works from $30.00 to $32.00 and gave the stock an “equal weight” rating in a research note on Friday, August 29th. JPMorgan Chase & Co. reiterated a “neutral” rating and set a $26.00 target price on shares of Bath & Body Works in a research note on Monday, October 6th. Jefferies Financial Group lowered their target price on Bath & Body Works from $32.00 to $28.50 and set a “hold” rating on the stock in a research note on Monday. Finally, Telsey Advisory Group reiterated an “outperform” rating and set a $38.00 target price on shares of Bath & Body Works in a research note on Thursday, August 28th. Eleven equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $37.46.

Bath & Body Works Stock Performance

Shares of Bath & Body Works stock opened at $25.78 on Thursday. Bath & Body Works, Inc. has a 52-week low of $24.85 and a 52-week high of $41.87. The stock’s 50-day simple moving average is $27.84 and its 200 day simple moving average is $29.17. The stock has a market capitalization of $5.31 billion, a P/E ratio of 7.65, a P/E/G ratio of 0.90 and a beta of 1.52.

Bath & Body Works (NYSE:BBWI) last announced its quarterly earnings data on Thursday, August 28th. The company reported $0.37 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.37. Bath & Body Works had a negative return on equity of 48.43% and a net margin of 9.88%.The business had revenue of $1.55 billion for the quarter, compared to analysts’ expectations of $1.55 billion. During the same period in the previous year, the business posted $0.37 EPS. The firm’s quarterly revenue was down .8% compared to the same quarter last year. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. Equities research analysts forecast that Bath & Body Works, Inc. will post 3.3 EPS for the current fiscal year.

Bath & Body Works Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 5th. Stockholders of record on Friday, August 22nd were issued a dividend of $0.20 per share. The ex-dividend date of this dividend was Friday, August 22nd. This represents a $0.80 annualized dividend and a dividend yield of 3.1%. Bath & Body Works’s payout ratio is presently 23.74%.

Bath & Body Works Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.